Joe, safe travels. Good luck in China. Adding coronavirus II-key hybrid data along with SARS, h5n1, “bet v” allergen (Stellergens) greatly strengthens another side of the ngio portfolio.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links